BlackRock Advisors’s Collegium Pharmaceutical COLL Stock Holding History

BlackRock Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$155K	Buy	9,951 +3,050	+44%	+$50.7K	﹤0.01%	2837
2016 Q3	$133K	Buy	6,901 +857	+14%	+$10.2K	﹤0.01%	2893
2016 Q2	$72K	Buy	6,044 +1,909	+46%	+$31.5K	﹤0.01%	3109
2016 Q1	$75K	Buy	4,135 +1,811	+78%	+$32.9K	﹤0.01%	3046
2015 Q4	$64K	Sell	2,324 -1,083	-32%	-$22.8K	﹤0.01%	3107
2015 Q3	$75K	Buy	3,407 +36	+1%	+$651	﹤0.01%	3201
2015 Q2	$60K	Buy	+3,371	New	+$58.3K	﹤0.01%	3301

Other funds holding COLL

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock Advisors's COLL Position: Q4 2016 in Review

BlackRock Advisors increased its Collegium Pharmaceutical (COLL) stake by 44% in Q4 2016, buying an estimated $50.7K and bringing the position to 9,951 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

BlackRock Advisors first reported a position in COLL in Q2 2015 and has held it in 7 quarters since. 88 funds tracked by Wall St. Rank hold COLL as of Q4 2016.

BlackRock Advisors held 9,951 shares of Collegium Pharmaceutical worth $155K as of Q4 2016.
BlackRock Advisors bought 3,050 Collegium Pharmaceutical shares in Q4 2016, an estimated $50.7K.
Collegium Pharmaceutical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2837 holding.
BlackRock Advisors first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 7 quarters since.
88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.